How Can Blockchain Be Implemented In The Pharmaceutical Industry?

| November 15, 2019

article image
Blockchain owns its reputation by providing many valuable advantages for everyday business and more complex operations. In this article, we want to disclose how the technology could be and already is implemented in the pharmaceutical industry. Moreover, we will discuss track and trace potential in this topic.

Spotlight

IMS Consulting Group

IMSCG is the leading global consulting firm focused exclusively on life sciences. Our clients range from the large pharmaceutical and biotech companies to entrepreneurial companies preparing for their first launch. We collaborate with our clients to make critical business decisions, build commercial excellence, and grow their businesses in an increasingly challenging environment.

OTHER ARTICLES

Advance Your Pharma Supply Chain Planning during a Pandemic

Article | March 20, 2020

One predominant and common element within our pharmaceutical industry, is our devotions to patients. Within supply chain there is always a focus on ensuring the right product is delivered to the right place at the right time in order to ensure patient safety and the continuity of medicinal supplies. With the spread of COVID-19 across 117 countries and counting, every supply chain needs to evaluate their global footprint and develop contingency plans within their end to end operations.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | March 20, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Clinical Development Risks and Issues in a COVID-19 World

Article | March 20, 2020

Global clinical guidelines have shifted the industry toward risk-based approaches for the planning and execution of clinical trials. The ICH’s guidelines for Good Clinical Practice state that sponsors should evaluate identified risks against existing risk controls by considering “the likelihood of errors occurring, the extent to which such errors would be detectable, and the impact of such errors on human subject protection and reliability of trial results” (ICH E6 R2).

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | March 20, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Spotlight

IMS Consulting Group

IMSCG is the leading global consulting firm focused exclusively on life sciences. Our clients range from the large pharmaceutical and biotech companies to entrepreneurial companies preparing for their first launch. We collaborate with our clients to make critical business decisions, build commercial excellence, and grow their businesses in an increasingly challenging environment.

Events